Changes to the website
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 4952

Previous 25           Next 25
Website Changes
01/24/2017 Brain Surgery Made Safer With New Smart Needle
01/23/2017 The Musella Foundation announced that it has awarded a $10,000 brain tumor research grant
01/23/2017 Musella Foundation Request for Brain Tumor Research Grant Proposals
01/19/2017 Musella Foundation Copayment Assistance Program is now closed to new patients
01/19/2017 Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine
01/19/2017 New Study Aims to Extend TTFields Beyond Grade IV Brain Cancer Domain
01/19/2017 Glioblastoma Treatment Breakthrough: `Untreatable` Brain Cancer Tumor Stabilized With Malaria Drug
01/19/2017 Novocure’s Optune® Now Available at 500 Cancer Treatment Centers in the U.S.
01/15/2017 Immunotherapies for GBM: Tumor Vaccines by Linda Liau, M.D., Ph.D., M.B.A.
01/14/2017 National Walk To End Brain Tumors – Volunteers needed
01/13/2017 Salmonella Has Been Genetically Engineered to Consume Brain Tumors
01/03/2017 Musella Foundation Copay Assistance Program reopens!
12/31/2016 Florescent light helps surgeons target brain tumors
12/31/2016 Pathway linked to slower aging also fuels brain cancer
12/31/2016 Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
12/31/2016 A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastomas.
12/31/2016 Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry and in situ hybridization.
12/31/2016 Top Brain Tumor News Stories for 2016
12/29/2016 Novel Type of Immunotherapy Helps Man Fight Brain Cancer
12/25/2016 ONC201 Glioblastoma Trial to Expand Based on Promising Initial Results
12/25/2016 Some glioblastoma patients benefit from `ineffective` treatment, Stanford researchers say
12/25/2016 First patient enrolled in brain tumor trial combining 9 repurposed drugs - CUSP9v3 project
12/19/2016 Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
12/13/2016 Medicenna Announces Initiation of Phase 2 Clinical Trial of MDNA55 for the Treatment of Recurrent Glioblastoma
12/13/2016 Tocagen Expands Toca 5, Phase 2/3 Clinical Trial for Recurrent Brain Cancer, to Israel



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites